Skip to main content

Day: November 1, 2023

Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia (CLTI). Under the terms of the agreement, Inari will pay $250 million in cash at closing and LimFlow will be eligible to receive additional cash payments based on certain commercial and reimbursement milestones. The transaction is expected to close in the fourth quarter of 2023. LimFlow is transforming the treatment of CLTI, an advanced...

Continue reading

Enovix Completes Acquisition of Routejade

FREMONT, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced that it has completed the acquisition of privately-held Routejade, an established Korean battery manufacturer. The acquisition provides Enovix with vertical integration of electrode coating and battery pack manufacturing, while adding an established lithium-ion battery business with two factories in Korea, along with complementary products, customers, and suppliers. With coating now vertically integrated, Enovix intends to realize significant cost savings while speeding up battery development cycles as modern materials are quickly incorporated to improve energy density. Securing the coating supply chain is also intended to ensure incoming battery materials are the highest quality available,...

Continue reading

Aware® Reports Third Quarter and Nine Month 2023 Financial Results

Quarterly Total Revenue Increased 112% from prior year quarter to $6.4 Million Generated $2.5 million in Operating Cashflow in Q3 2023, the Highest Quarterly Level Since Q4 2018 BURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science, machine learning, and artificial intelligence to tackle everyday business and identity challenges through biometrics, today reported financial results for the third quarter ended September 30, 2023. Third Quarter 2023 and Nine Month 2023 Financial HighlightsTotal revenue for the third quarter of 2023 increased 112% to $6.4 million compared to $3.0 million in the third quarter of 2022. Total revenue for the nine months ended September 30, 2023, increased 16% to $13.9 million, compared to $11.9 million in the same...

Continue reading

MercadoLibre, Inc. Third Quarter 2023 Letter to Shareholders

Net Revenues of $3.8 billion, up 69.1% year-over-year on an FX neutral basisIncome from operations of $685 million, with a 18.2% margin$47.3 billion Total Payment Volume, up 121.2% year-over-year on an FX neutral basis$11.4 billion Gross Merchandise Volume, up 59.3% year-over-year on an FX neutral basis MONTEVIDEO, Uruguay, Nov. 01, 2023 (GLOBE NEWSWIRE) — MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com), Latin America’s leading e-commerce and technology company, today reported financial results for the quarter ended September 30, 2023. To our shareholders We have been investing relentlessly and consistently in our products and services for many years, and the powerful impact of these investments on our performance was clear to see in the third quarter of 2023 in the form of accelerated growth, customer preference...

Continue reading

InspireSemi To Participate in RISC-V Workshop and BoF Panel Discussion at SC23

VANCOUVER, British Columbia and AUSTIN, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that provides revolutionary high-performance, energy-efficient accelerated computing solutions for HPC, AI, graph analytics, and other compute-intensive workloads, is pleased to announce that it will participate in two sessions at the annual SC23, the International Conference for High Performance Computing, Networking, Storage, and Analysis, in Denver, Colorado, being held from November 12-17, 2023. Doug Norton, InspireSemi’s Chief Marketing Officer, will give a lightning talk on the Thunderbird next generation compute accelerator for HPC, AI, and graph analytics at the workshop on RISC-V for HPC being held from 2:00 P.M. – 5:30 P.M. MST on...

Continue reading

Correction: Aspo’s financial reporting in 2024

Aspo PlcStock Exchange ReleaseNovember 1, 2023 at 8.30 p.m. Correction: Aspo’s financial reporting in 2024 Aspo Plc corrects the stock exchange release published on November 1, 2023, at 11:00 a.m regarding Aspo’s financial reporting in 2024. In the original Finnish release, in paragraph four, in the sentence “Possible requests from shareholders to include matters on the agenda of Aspo’s 2024 Annual Shareholders’ Meeting shall be sent to Aspo’s Board of Directors not later than February 23, 2024” there was an incorrect year in connection with the date. In the English release, the year was correct. Aspo’s financial reporting in 2024 In 2024, Aspo Plc will publish its financial statement release, half year financial report and two interim reports as follows: – financial statement release for 2023 on Friday, February 16,...

Continue reading

Nokia Corporation: Repurchase of own shares on 01.11.2023

                           STOCK EXCHANGE RELEASE              01 November 2023                         Nokia CorporationStock Exchange Release              01 November 2023 at 21:00              Nokia Corporation: Repurchase of own shares on 01.11.2023                                                       Espoo, Finland – On 01 Nov 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:                                        Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*        AQEU 663 3.09        CEUX 41,582 3.10        TQEX 15,363 3.11        XHEL 392,392 3.11        Total 450,000 3.11        * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating...

Continue reading

Acorn, Provider of Remote Monitoring, Control and Electrical Grid Demand Response Solutions for Backup Generators, Hosts Q3 Investor Call Thur., Nov. 9th at 11am ET

WILMINGTON, Del., Nov. 01, 2023 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for stand-by power generators, gas pipelines, air compressors, and other critical equipment, will host its third quarter conference call, Thursday, November 9th at 11:00 a.m. ET. Jan Loeb, President & CEO, and Tracy Clifford, CFO of Acorn & COO of OmniMetrix, will review Acorn’s results and outlook and answer investor questions. Financial results will be released that morning before markets open.Conference Call & Replay  Date/Time: Thursday, November 9th at 11:00 am ETDial-in Number: 1-844-834-0644 or 1-412-317-5190 (Int’l)Online Replay/Transcript: Audio file/transcript will be posted online hereQuestions can also be submitted via Email: acfn@catalyst-ir.comAbout...

Continue reading

InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23

Data demonstrate a low major adverse event rate of 0.95% through 30 days post-procedure TEL AVIV, Israel and MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today presented 30-day results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) clinical trial at the Vascular InterVentional Advances (VIVA) meeting, which is being held October 30 through November 2 in Las Vegas, NV. The presentation, which was accepted as a late-breaking abstract, was delivered by Dr. Chris Metzger, System Vascular Chief at OhioHealth in Columbus, OH and principal investigator of the C-GUARDIANS trial. C-GUARDIANS is a pivotal trial designed to evaluate the safety and efficacy of the CGuard™ Carotid Stent System...

Continue reading

Post Onepoint announcement communication

Post Onepoint announcement communication    Paris, France – November 1st, 2023 – Atos has taken note of the announcement by Onepoint this afternoon [November 1st, 2023]. We welcome Onepoint, a French company well recognized in the digital transformation space, as a new anchor investor of Atos and look forward to a constructive dialogue with them as with all other shareholders of the Group in the best interest of all stakeholders.    Contacts Investor contact:                                investors@atos.net Individual shareholders contact:           0805 65 00 75 Media:                                              globalprteam@atos.net About Atos Atos is a global leader in digital transformation with 105,000 employees and annual revenue of c. € 11 billion. European number one in cybersecurity, cloud and high-performance computing, the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.